CLINICAL RESEARCH: CORONARY DISEASE RISK
Persistent Impairment of Endothelial Vasomotor Function Has a Negative Impact on Outcome in Patients With Coronary Artery Disease
Yoshinobu Kitta, MD, PhD,
Jyun-ei Obata, MD, PhD,
Takamitsu Nakamura, MD,
Mitsumasa Hirano, MD,
Yasushi Kodama, MD,
Daisuke Fujioka, MD, PhD,
Yukio Saito, MD,
Ken-ichi Kawabata, MD, PhD,
Keita Sano, MD,
Tsuyoshi Kobayashi, MD,
Toshiaki Yano, MD,
Kazuto Nakamura, MD, PhD and
Kiyotaka Kugiyama, MD, PhD*
Department of Internal Medicine II, University of Yamanashi, Faculty of Medicine, Yamanashi, Japan
Manuscript received April 10, 2008;
revised manuscript received August 6, 2008,
accepted August 30, 2008.
* Reprint requests and correspondence: Dr. Kiyotaka Kugiyama, Department of Internal Medicine II, University of Yamanashi, Faculty of Medicine, 1110 Shimokato, Chuo 409-3898, Japan (Email: kugiyama{at}yamanashi.ac.jp).
Objectives: We assessed the hypothesis that changes in endothelial vasomotor function in response to optimized therapy for atherosclerotic coronary artery disease predict future cardiovascular events.
Background: Although endothelial vasomotor dysfunction is a predictor of cardiovascular events, it remains unclear whether reversibility of endothelial dysfunction in response to risk factor reduction provides prognostic information.
Methods: This study included 251 patients with newly diagnosed coronary artery disease and an impaired flow-mediated dilation (FMD) of the brachial artery (FMD <5.5%). Measurement of FMD was repeated after 6 months for individualized and optimized therapy to reduce risk factors according to American College of Cardiology/American Heart Association guidelines. Patients were followed up for 36 months or until 1 of the following events occurred: cardiac death, nonfatal myocardial infarction, recurrent and refractory angina pectoris requiring coronary revascularization, or ischemic stroke.
Results: FMD was persistently impaired (<5.5%) in 104 (41%) patients after 6 months of optimized therapy, whereas it improved (FMD  5.5%) in the remaining 147 (59%) patients. During 36 months of follow-up, events occurred in 27 (26%) patients with persistently impaired FMD and in 15 (10%) patients with improved FMD (p < 0.01 by chi-square test). Multivariate Cox hazards analysis showed that persistent impairment of FMD was an independent predictor of events (hazard ratio: 2.9, 95% confidence interval: 1.5 to 6.2, p < 0.01). Baseline FMD before the optimized therapy to reduce risk factor had no significant prognostic information.
Conclusions: Persistent impairment of endothelial vasomotor function despite optimized therapy to reduce risk factors has an adverse impact on outcome in coronary artery disease patients.
Key Words: endothelium • prognosis • coronary artery disease • risk factor
|
Abbreviations and Acronyms
| | CAD = coronary artery disease | | CVD = cardiovascular disease | | EDNO = endothelium-derived nitric oxide | | FMD = flow-mediated dilation | | Hb = hemoglobin | | LDL-C = low-density lipoprotein cholesterol | | ROC = receiver-operator characteristic |
|
Related Articles
-
Individualized Approach to the Management of Coronary Heart Disease: Identifying the Nonresponders Before It Is Too Late
- Peter Ganz and Priscilla Y. Hsue
J. Am. Coll. Cardiol. 2009 53: 331-333.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2009 53: A20.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
P. Ganz and P. Y. Hsue
Individualized approach to the management of coronary heart disease identifying the nonresponders before it is too late.
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
331 - 333.
[Full Text]
[PDF]
|
|
|
|
